BiotechTube
Home/Neuromagen Pharma/Mr. Iftach Seri, M.Sc., MBA
MI

Mr. Iftach Seri, M.Sc., MBA

CEO, CTS Ltd.

Neuromagen Pharma

Therapeutic Areas

NeurodegenerationAlzheimer's diseaseCardiovascular agingMetabolic diseaseReproductive healthHair and skin rejuvenationAnti‑aging

Neuromagen Pharma Pipeline

DrugIndicationPhase
AGS‑499Amyotrophic Lateral Sclerosis (ALS)Preclinical

Leadership Team at Neuromagen Pharma

PE
Prof. Esther Priel, DSc
Founder, CEO & CSO
DD
Daniella Dayan, B.Sc., MBA
Chief Operating Officer
DH
Dr. Helena Grinberg‑Rashi, Ph.D., MBA
Senior Clinical and Regulatory Advisor
DE
Dr. Elad Bar Gil, MD
Chief Medical Officer
DH
Dr. Hananel Elul, Ph.D.
Researcher
DT
Dr. Tatyana Glukovsky, Ph.D.
Researcher
PG
Prof. Gal Ifergane, MD
Scientific Advisory Board, Head of Brain Medicine Division
PD
Prof. David Stepensky, Ph.D.
Scientific Advisory Board
View full Neuromagen Pharma profile